L-165041 is a phenyloxyacetate PPARδ receptor agonist. It is less potent and PPARδ selective than GW 501516.
List of articles in "Drug" category - Page 18
MBX-8025
MBX-8025 is a PPARδ receptor agonist that is being investigated for drug use by Metabolex. According to a press release they are examining its potential use for the treatment of […]
Glycerol phenylbutyrate
Glycerol phenylbutyrate (USAN) trade name Ravicti is a medication used in the treatment of certain inborn urea cycle disorders. The medication works by preventing the harmful build up of ammonia […]
GW0742
GW0742 (also known as GW610742) is a PPARδ/β agonist that is investigated for drug use by GlaxoSmithKline.[citation needed]
GFT505
GFT505 is a research drug that is being developed by Genfit for the treatment of cardiometabolic diseases including diabetes insulin resistance dyslipidemia and non-alcoholic fatty liver disease (NAFLD).GFT505 is a […]
AB-005
AB-005 or [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl](2233-tetramethylcyclopropyl)-methanone is a designer drug offered by online vendors as a cannabimimetic agent. The structure and pharmacological activity of AB-005 was published in 2010 prior to its commercial […]
5F-PB-22
5F-PB-22 or 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester is a designer drug and a possible cannabinoid agonist. The structure of 5F-PB-22 appears to utilise an understanding of structure-activity relationships within the indole […]
QUCHIC
QUCHIC (BB-22 or 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent and was first detected being sold in synthetic cannabis products in […]
QUPIC
QUPIC (PB-22 or 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent and detected being sold in synthetic cannabis products in Japan in […]
Tofogliflozin
Tofogliflozin (USAN codenamed CSG452) is an experimental drug for the treatment of diabetes mellitus and is being developed by Chugai Pharma in collaboration with Kowa and Sanofi. It is an […]